Veradermics, An IPO Stock, Skyrockets On Oral Rogaine Results
Key Points:
- Investor’s Business Daily (IBD) provides information for educational purposes only and does not offer investment advice or recommendations to buy or sell securities.
- The information is sourced from what IBD believes are reliable sources but comes without guarantees regarding accuracy, timeliness, or suitability.
- Past investment performance shared by IBD does not predict future results, and authors may hold positions in the stocks they discuss.
- IBD disclaims warranties about the advisability of any investment or strategy and notes that information is subject to change without notice.
- Real-time prices are provided by Nasdaq Last Sale, with ownership and estimate data from LSEG and FactSet, while trademarks belong to Investor’s Business Daily, LLC.